ロード中...
Cytomegalovirus (CMV) resistance in CD34(+) selected hematopoietic cell transplant (HCT) recipients
BACKGROUND: Cytomegalovirus (CMV) viremia after CD34(+) selected hematopoietic stem cell transplant (HCT) often requires prolonged antiviral therapy. We report rates and outcomes of resistant CMV in a contemporary cohort of CD34(+) selected HCT recipients managed preemptively. METHODS: We retrospect...
保存先:
| 出版年: | Transpl Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5988949/ https://ncbi.nlm.nih.gov/pubmed/29570237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12881 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|